nDatalyze Corp. Unveils Promising Clinical Study Outcomes
Company Announcements

nDatalyze Corp. Unveils Promising Clinical Study Outcomes

Story Highlights

nDatalyze Corp (TSE:NDAT) has released an update.

nDatalyze Corp. reports that their innovative clinical study showcases promising results, indicating that their expert-guided approach to predicting depression probabilities outperforms standard machine learning methods. This breakthrough suggests potential for developing two distinct, cost-effective product pathways that leverage machine learning with minimal recalibration.

For further insights into TSE:NDAT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdesknDatalyze Corp Announces Presidential Leadership Change
TipRanks Canadian Auto-Generated NewsdesknDatalyze Corp Reactivates OTCQB Listing in the US
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App